Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

411
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization and optimization of antifungal production in <i>Streptomyces</i> sp. RMIT01 from the Australian mangrove rhizosphere.

PeerJ·2026
Same author

Clinical observations of tetanus toxin plus decoy, Snoretox-1, a novel targeted neuromuscular stimulant, in a pilot study of 6 British bulldogs with BOAS.

Veterinary journal (London, England : 1997)·2026
Same author

Designing Scalable Mechano-Virucidal Nanostructured Acrylic Surfaces for Enhanced Viral Inactivation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Eco-friendly non-isocyanate polyurethane and carboxymethyl cellulose composite films reinforced with sodium lignosulfonate for sustainable packaging applications.

International journal of biological macromolecules·2026
Same author

Targeted Chemical Profiling and Dereplication of Australian Plants of the Family Haemodoraceae Using a Combined HPLC-MS and HRLC(ESI)-MS Approach.

Molecules (Basel, Switzerland)·2025
Same author

Navigating Therapies, Challenges, and Recommendations for Treatment-Resistant Peripartum Depression: A Comprehensive Review.

Healthcare (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 10, 2025

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.3K

An Evaluation of Urease A Subunit Nanocapsules as a Vaccine in a Mouse Model of Helicobacter pylori Infection.

Ivana Skakic1, Jasmine E Francis1, Chaitali Dekiwadia2

  • 1School of Science, RMIT University, 264 Plenty Road, Bundoora, VIC 3083, Australia.

Vaccines
|November 25, 2023
PubMed
Summary

Protein nanocapsules were synthesized using silica templates to create potential vaccines against Helicobacter pylori. Larger nanocapsules, when combined with an adjuvant, significantly reduced bacterial colonization in mice.

Keywords:
Helicobacter pylorinanocapsulesilica nanoparticle templateurease alpha subunitvaccination

More Related Videos

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

9.8K
Mouse Models Of Helicobacter Infection And Gastric Pathologies
07:43

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

20.0K

Related Experiment Videos

Last Updated: Jul 10, 2025

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.3K
One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

9.8K
Mouse Models Of Helicobacter Infection And Gastric Pathologies
07:43

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

20.0K

Area of Science:

  • Nanotechnology
  • Vaccine Development
  • Microbiology

Background:

  • Helicobacter pylori infection is a significant global health concern.
  • Developing effective vaccines against H. pylori remains a challenge.
  • Protein-based nanostructures offer a promising platform for vaccine delivery.

Purpose of the Study:

  • To synthesize and characterize protein nanocapsules using silica templates for potential H. pylori vaccines.
  • To evaluate the immunogenicity and protective efficacy of these nanocapsules in a mouse model.

Main Methods:

  • Synthesis of protein nanocapsules (UreA subunit of H. pylori urease) using two types of silica templates (SC/MS and MS) of different sizes.
  • Characterization of nanocapsule size, monodispersity, and homogeneity.
  • Vaccination of mice with different nanocapsule formulations and an adjuvant.
  • Assessment of immune responses and reduction in H. pylori colonization.

Main Results:

  • Two sizes of monodisperse protein nanocapsules (510 nm and 47 nm) were successfully synthesized.
  • Vaccination with larger nanocapsules (510 nm) combined with an adjuvant significantly reduced H. pylori colonization in mice.
  • Immune responses were evaluated, indicating the potential efficacy of the nanocapsule vaccine.

Conclusions:

  • Protein nanocapsules, particularly larger ones formulated with an adjuvant, show promise as a vaccine strategy against H. pylori infection.
  • This study demonstrates a novel approach for developing subunit vaccines using nanotechnology.
  • Further research is warranted to optimize the formulation and assess long-term efficacy.